Antagonists of intestinotrophic GLP-2 peptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5994500
SERIAL NO

08683890

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antagonists of glucagon-like peptide 2, have been identified. Their effects on the growth of gastrointestinal tissue are described. Its formulation as a pharmaceutical, and its therapeutic and related uses in treating bowel tissue, are described. Also described are methods of identifying antagonists of glucagon-like peptide 2.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NPS PHARMACEUTICALS INC550 HILLS DRIVE 3RD FLOOR BEDMINSTER NJ 07921

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Crivici, Anna E Toronto, CA 9 258
Drucker, Daniel J Toronto, CA 38 896
Sumner-Smith, Martin Bolton, CA 20 645

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation